Insilico Medicine and Liquid AI Partner on Lightweight Foundation Models for Drug Discovery

Summary

Insilico Medicine and Liquid AI announced a strategic partnership to develop lightweight scientific foundation models tailored for pharmaceutical drug discovery. The collaboration has produced LFM2-2.6B-MMAI (v0.2.1), a single 2.6-billion-parameter model that reportedly achieves state-of-the-art performance across multiple drug discovery benchmarks while being compact enough to run entirely on private pharmaceutical infrastructure. The model is notable for its efficiency — consolidating capabil